Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant
Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Paulina Misztak, et al.
Pharmacological Reports (2017) Vol. 69, Iss. 4, pp. 595-601
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Effects of Antidepressants on Sleep
Adam Wichniak, Aleksandra Wierzbicka, Małgorzata Walęcka, et al.
Current Psychiatry Reports (2017) Vol. 19, Iss. 9
Open Access | Times Cited: 404
Molecular aspects of depression: A review from neurobiology to treatment
Gustavo Roberto Villas Boas, Roseli Boerngen de Lacerda, Marina Meirelles Paes, et al.
European Journal of Pharmacology (2019) Vol. 851, pp. 99-121
Closed Access | Times Cited: 113
5-HT Receptors and the Development of New Antidepressants
Grzegorz Ślifirski, Marek Król, Jadwiga Turło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9015-9015
Open Access | Times Cited: 72
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons
Krishna C. Vadodaria, Yuan Ji, Michelle Skime, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 6, pp. 795-807
Closed Access | Times Cited: 71
Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research
Djamila Bennabi, Émmanuel Haffen, Vincent Van Waes
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 61
Lactate: a prospective target for therapeutic intervention in psychiatric disease
Yanhui Cai, Haiyun Guo, Tianle Han, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1473-1479
Open Access | Times Cited: 13
Chronic orofacial pain and pharmacological management – a Clinical guide
Guangzhao Guan, A Polonowita, Li Mei, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2025)
Open Access
Post-marketing safety surveillance of vortioxetine hydrobromide: a pharmacovigilance study leveraging FAERS database
Ying Zhang, Shengzhu Sun, Yaogui Ning
Frontiers in Psychiatry (2025) Vol. 16
Open Access
A Stratified Precision Medicine Trial Targeting Selective Mechanisms of Alpha 2A Agonism as a Treatment for the Cognitive Biotype of Depression: The BIomarker Guided (BIG) Study for Depression
Leanne M. Williams, Laura M. Hack, Jenna Jubeir, et al.
Research Square (Research Square) (2025)
Closed Access
Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
Shilpa Sharma, Ravi Shankar Akundi
Current Neuropharmacology (2018) Vol. 17, Iss. 6, pp. 550-562
Open Access | Times Cited: 39
Pharmacological treatment of acute-phase anorexia nervosa: Evidence from randomized controlled trials
Emanuele Cassioli, Carolina Sensi, Edoardo Mannucci, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 8, pp. 864-873
Closed Access | Times Cited: 32
Minocycline treatment improves cognitive and functional plasticity in a preclinical mouse model of major depressive disorder
S. Poggini, María Banqueri, N. Ciano Albanese, et al.
Behavioural Brain Research (2023) Vol. 441, pp. 114295-114295
Closed Access | Times Cited: 11
Vortioxetine Ameliorates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in Mice via Activation of PI3K/Akt/CREB/BDNF cascade and Modulation of Serotonergic Pathway Signaling
Marwa S Shafiek, Radwa Y. Mekky, Noha N. Nassar, et al.
European Journal of Pharmacology (2024) Vol. 982, pp. 176929-176929
Closed Access | Times Cited: 4
Use of vortioxetine in different neurological fields: a systematic review and future perspectives
Giulio Verrienti, Isabella Colonna, Cecilia Raccagni
Neurological Sciences (2025)
Closed Access
Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy
Ana Micov, Maja Tomić, Marija B. Todorović, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 103, pp. 109975-109975
Closed Access | Times Cited: 31
Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial
Ehsan Moazen‐Zadeh, Samaneh Bayanati, Kimia Ziafat, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 5, pp. 506-513
Closed Access | Times Cited: 28
Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double‐blind randomized trial
Firouzeh Borhannejad, Behnam Shariati, Sina Naderi, et al.
Journal of Clinical Pharmacy and Therapeutics (2020) Vol. 45, Iss. 4, pp. 804-811
Open Access | Times Cited: 28
The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
Roger S. McIntyre, Mehala Subramaniapillai, Caroline Park, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 28
Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity
Alaeddine Djillani, Mariel Piétri, Sébastien Moréno, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 30
Vortioxetine versus other antidepressants in the treatment of burning mouth syndrome: An open‐label randomized trial
Daniela Adamo, Giuseppe Pecoraro, Noemi Coppola, et al.
Oral Diseases (2020) Vol. 27, Iss. 4, pp. 1022-1041
Closed Access | Times Cited: 26
Evaluation of 5-HT7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice
Olivia M. Balcer, Matthew A. Seager, Scott D. Gleason, et al.
Behavioural Brain Research (2018) Vol. 360, pp. 270-278
Closed Access | Times Cited: 25
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Daniela Adamo, Elena Calabria, Noemi Coppola, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 18
Photobiomodulation improves depression symptoms: a systematic review and meta-analysis of randomized controlled trials
Qipei Ji, Shichang Yan, Ding Ji-lin, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 2
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study
Domenico De Berardis, Michele Fornaro, Annalisa Anastasia, et al.
Brazilian Journal of Psychiatry (2020) Vol. 42, Iss. 3, pp. 317-321
Open Access | Times Cited: 18
Strategies for antidepressants extraction from biological specimens using nanomaterials for analytical purposes: A review
Khaled Murtada, Fernando de Andrés, Mohammed Zougagh, et al.
Microchemical Journal (2019) Vol. 150, pp. 104193-104193
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top